The Audiologist Informer

Andrew Bellavia reports on his experiences at a Lincoln Center concert using ReSound Nexia and a beta version app featuring Auracast.

Preclinical trials suggest AC102 offers hope as an effective treatment for acute sudden hearing loss. It has now passed Phase I safety trials, and a Phase II study to confirm efficacy in patients is now underway in Europe.

HearingTracker Audiologist Matthew Allsop delves into Phonak Infinio hearing aid technology, providing an overview of 16 innovative models.

GN released its third-quarter report that was substantially better than expected. The parent company of ReSound, Beltone, and Jabra gained significant market share with 10% organic revenue growth, including 10% in GN Hearing driven by ReSound Nexia.

CMS is finalizing a 2.83% cut for Medicare services in CY 2025. This article from AAA links to a table showing how the cuts will affect audiology service payments and also provides information on the proposed ending of COVID-era telehealth flexibility.

The Group saw organic growth of 2%, driven entirely by very strong performance in Hearing Care. Hearing Aids saw organic growth in revenue from external customers of -1%, which is slightly below expectations in a soft hearing aid market, while Hearing Care and Diagnostics saw 7% and -4% organic growth, respectively.

In this video, Apple's John Ternus, SVP of Hardware Engineering, and Sumbul Desai, VP of Health, discuss how they built the AirPods Pro 2 All-In-One Hearing Features.

Using data from the National Health and Nutrition Examination Survey (NHANES) and Mendelian randomization (MR) basic databases, researchers demonstrated that mild and moderate hearing loss significantly increased the risk of gout, and MR analysis further “confirmed the causal relationship between hearing loss and gout.”